The Ca²⁺ Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal

• Main Authors: José Ignacio Veytia-Bucheli (Author), Den Alejandro Alvarado-Velázquez (Author), Lourival Domingos Possani (Author), Roberto González-Amaro (Author), Yvonne Rosenstein (Author)
• Format: Book
• Published: MDPI AG, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ca²⁺ channel blockers (CCBs) are commonly used to treat different cardiovascular conditions. These drugs disrupt the intracellular Ca²⁺ signaling network, inhibiting numerous cellular functions in different cells, including T lymphocytes. We explored the...